Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis | Stroke and Vascular Neurology

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest Content

Current issue

Archive

For authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Original research

Who may benefit from lower dosages of intravenous tissue plasminogen activator? Results from a cluster data analysis

Online download statistics by month:

Online download statistics by month: July 2020 to March 2024

	Abstract	Full	Pdf
Jul 2020	304	299	103
Aug 2020	115	115	27
Sep 2020	68	64	30
Oct 2020	56	49	14
Nov 2020	49	39	22
Dec 2020	71	65	21
Jan 2021	104	101	36
Feb 2021	63	62	30
Mar 2021	61	61	22
Apr 2021	41	39	18
May 2021	36	36	14
Jun 2021	51	39	16
Jul 2021	37	34	8
Aug 2021	27	25	9
Sep 2021	32	30	19
Oct 2021	46	46	27
Nov 2021	37	35	23
Dec 2021	25	26	1
Jan 2022	137	137	10
Feb 2022	22	26	12
Mar 2022	47	46	15
Apr 2022	54	53	16
May 2022	43	44	16
Jun 2022	45	43	12
Jul 2022	34	34	13
Aug 2022	41	40	11
Sep 2022	48	37	14
Oct 2022	45	41	11
Nov 2022	36	35	25
Dec 2022	26	24	5
Jan 2023	17	17	12
Feb 2023	47	45	7
Mar 2023	29	28	12
Apr 2023	15	14	13
May 2023	15	14	12
Jun 2023	18	19	8
Jul 2023	18	17	19
Aug 2023	40	40	10
Sep 2023	46	46	16
Oct 2023	30	27	10
Nov 2023	60	45	5
Dec 2023	55	54	12
Jan 2024	40	41	21
Feb 2024	34	34	9
Mar 2024	31	30	52
Total	2296	2196	818